Ehab L Atallah

9PUBLICATIONS
44CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 15, 2026
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.

|Aug 31, 2026
Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study.

|Oct 07, 2025
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase.

Ehab Atallah, Michael S Broder, Onyee Chan

|Dec 05, 2024
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations.

Ehab Atallah, Michael Deininger

|Oct 17, 2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results from the ECOG-ACRIN EA9152 protocol.

Neil D Palmisiano, Ju-Whei Lee, David F Claxton

|Jul 03, 2023
Real-world Management of CML: Outcomes and Treatment Patterns.

Nicole Held, Ehab L Atallah

Pageof 2

Frequent Collaborators

3 joint publications

Guru Subramanian Guru Murthy

2 joint publications

Vamsi Kota

2 joint publications

Kathryn E Flynn

2 joint publications

Adam S DuVall